The use of ferroptosis inducers to inhibit solute carrier family 7 member 11 (SLC7A11) or glutathione peroxidase 4 (GPX4) activity can enhance the sensitivity of tumor cells to radiotherapy (RT) [14,15]. This evidence concerns the gene GPX4 and neoplasm.